Ailux https://ailuxbio.com/ AI-Powered Biologics Discovery Thu, 26 Feb 2026 06:31:59 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.1 https://ailuxbio.com/wp-content/uploads/2024/02/cropped-Screenshot-2024-02-15-at-10.07.03-AM-32x32.png Ailux https://ailuxbio.com/ 32 32 Ailux Selected for Digital Oral and Poster Presentations at ECCO’26, Highlighting Potential for Novel IBD Treatment https://ailuxbio.com/ailux-selected-for-digital-oral-and-poster-presentations-at-ecco26-highlighting-potential-for-novel-ibd-treatment/?utm_source=rss&utm_medium=rss&utm_campaign=ailux-selected-for-digital-oral-and-poster-presentations-at-ecco26-highlighting-potential-for-novel-ibd-treatment Wed, 18 Feb 2026 20:14:57 +0000 https://ailuxbio.com/?p=2189 February 17, 2026 SHANGHAI (CHINA) and SOMERVILLE, MA (US) — February 17, 2026 — Ailux, an AI-native biologics innovator and a subsidiary of XtalPi (2228.HK), a global leader in AI

The post Ailux Selected for Digital Oral and Poster Presentations at ECCO’26, Highlighting Potential for Novel IBD Treatment appeared first on Ailux.

]]> Antibody Engineering & Therapeutics 2025 USA https://ailuxbio.com/antibody-engineering-therapeutics-2025-usa/?utm_source=rss&utm_medium=rss&utm_campaign=antibody-engineering-therapeutics-2025-usa Thu, 08 Jan 2026 17:20:59 +0000 https://ailuxbio.com/?p=2185 December 15, 2025

The post Antibody Engineering & Therapeutics 2025 USA appeared first on Ailux.

]]> PEGS Europe 2025 https://ailuxbio.com/pegs-europe-2025/?utm_source=rss&utm_medium=rss&utm_campaign=pegs-europe-2025 Fri, 12 Dec 2025 09:00:23 +0000 https://ailuxbio.com/?p=2179 November 12, 2025 Presentation by Mary Ann Pohl, Ph.D., Director of Alliance Management, Ailux

The post PEGS Europe 2025 appeared first on Ailux.

]]> XtalPi Subsidiary Ailux Announces Strategic Collaboration with Lilly to Advance Bispecific Antibody Development https://ailuxbio.com/ailux-lilly-collaboration-2025-11-05/?utm_source=rss&utm_medium=rss&utm_campaign=ailux-lilly-collaboration-2025-11-05 Wed, 05 Nov 2025 10:42:38 +0000 https://ailuxbio.com/?p=2133 November 5, 2025 SHANGHAI (CHINA) — November 5, 2025 — Ailux, an innovator in AI-powered biologics and a wholly owned subsidiary of XtalPi (2228.HK), a global leader in AI drug

The post XtalPi Subsidiary Ailux Announces Strategic Collaboration with Lilly to Advance Bispecific Antibody Development appeared first on Ailux.

]]> Ailux Announces Posters at American College of Rheumatology (ACR) Convergence 2025 https://ailuxbio.com/ailux-announces-posters-at-american-college-of-rheumatology-acr-convergence-2025/?utm_source=rss&utm_medium=rss&utm_campaign=ailux-announces-posters-at-american-college-of-rheumatology-acr-convergence-2025 Sun, 02 Nov 2025 06:24:02 +0000 https://ailuxbio.com/?p=2116 October 27, 2025 SHANGHAI (CHINA) and SOMERVILLE, MA (US) — October 27, 2025 — Ailux, an innovator in AI-powered biologics and a subsidiary of XtalPi (2228.HK), a global leader in

The post Ailux Announces Posters at American College of Rheumatology (ACR) Convergence 2025 appeared first on Ailux.

]]> Ailux, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform https://ailuxbio.com/ailux-janssen-ai-license/?utm_source=rss&utm_medium=rss&utm_campaign=ailux-janssen-ai-license Thu, 31 Jul 2025 05:58:06 +0000 https://ailux.xtalpi.com/?p=1981 October 10, 2024 CAMBRIDGE, MA – October 10, 2024 – XtalPi, a global leader in AI drug discovery, announced today a license agreement between Ailux Biologics, a division of XtalPi

The post Ailux, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform appeared first on Ailux.

]]> PEGS Boston 2025 https://ailuxbio.com/pegs-boston-2025/?utm_source=rss&utm_medium=rss&utm_campaign=pegs-boston-2025 Fri, 18 Jul 2025 16:27:10 +0000 https://ailux.xtalpi.com/?p=1805 July 18, 2025 Presentation by Patrick Doonan, Ph.D., Director of Alliance Management, Ailux

The post PEGS Boston 2025 appeared first on Ailux.

]]> UCB Partners with Ailux, a Division of XtalPi, on Biologics AI Platform https://ailuxbio.com/ucb-ailux-xtalfold-partnership/?utm_source=rss&utm_medium=rss&utm_campaign=ucb-ailux-xtalfold-partnership Thu, 09 Jan 2025 13:00:00 +0000 https://ailux.xtalpi.com/?p=1193 January 9, 2025 Computational advancements enable earlier and more widespread use of antibody-antigen structural insights across drug discovery process These advancements have the potential to transform antibody discovery methods, broadening

The post UCB Partners with Ailux, a Division of XtalPi, on Biologics AI Platform appeared first on Ailux.

]]> Antibody Therapeutics & Engineering 2024 USA https://ailuxbio.com/aet-us-2024/?utm_source=rss&utm_medium=rss&utm_campaign=aet-us-2024 Fri, 20 Dec 2024 08:21:24 +0000 https://ailux.xtalpi.com/?p=1175 December 20, 2024 Presentation by Barry Duplantis, Ph.D., Director of Global Business Development, Ailux

The post Antibody Therapeutics & Engineering 2024 USA appeared first on Ailux.

]]> PEGS Europe 2024 https://ailuxbio.com/pegs-europe-2024/?utm_source=rss&utm_medium=rss&utm_campaign=pegs-europe-2024 Thu, 21 Nov 2024 18:24:06 +0000 https://ailux.xtalpi.com/?p=1159 November 11, 2024 Presentation by Mary Ann Pohl, Ph.D., Director of Alliance Management, Ailux

The post PEGS Europe 2024 appeared first on Ailux.

]]>